BCLI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.15%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Brainstorm Cell Therapeutics Insider Trading History Chart

Brainstorm Cell Therapeutics Share Price & Price History

^$0.56

▼ -0.0374 (-6.23%)

As of 12/19/2025 04:29 PM ET

Days: 30 | 90 | 365

Brainstorm Cell Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/30/2024	Chaim Lebovits	CEO	Buy	1,466	$3.45	$5,057.70	79,124
7/19/2024	Ibrahim B. Dagher	Insider	Sell	4,200	$5.25	$22,050.00
9/1/2023	Stacy Lindborg	CEO	Buy	766	$26.55	$20,337.30	12,100

SEC Filings (Institutional Ownership Changes) for Brainstorm Cell Therapeutics (NASDAQ:BCLI)

14.33% of Brainstorm Cell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Brainstorm Cell Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/24/2025	Gunderson Capital Management Inc.	25,950	$29K	0.0%	N/A	0.264%
5/15/2025	Armistice Capital LLC	690,666	$0.87M	0.0%	N/A	10.590%
2/14/2025	Two Sigma Securities LLC	11,300	$26K	0.0%	-42.9%	0.198%
2/12/2025	Geode Capital Management LLC	52,501	$0.12M	0.0%	-92.3%	0.921%
2/10/2025	Liberty Wealth Management LLC	22,666	$51K	0.0%	-93.3%	0.397%
1/8/2025	Weaver Consulting Group	15,623	$35K	0.0%	-93.3%	0.274%
8/15/2024	Armistice Capital LLC	7,917,653	$2.68M	0.0%	N/A	11.298%
4/15/2024	Kingswood Wealth Advisors LLC	81,050	$46K	0.0%	N/A	0.119%
8/14/2023	Mirador Capital Partners LP	25,084	$52K	0.0%	N/A	0.064%
8/9/2023	Kingswood Wealth Advisors LLC	16,600	$34K	0.0%	N/A	0.042%
7/31/2023	Socha Financial Group LLC	12,380	$26K	0.0%	N/A	0.031%
7/26/2023	Janney Montgomery Scott LLC	20,000	$41K	0.0%	N/A	0.051%
7/12/2023	Professional Financial Advisors LLC	17,279	$36K	0.0%	N/A	0.044%
5/15/2023	AIGH Capital Management LLC	1,459,095	$4.82M	1.8%	N/A	3.978%
5/10/2023	Nelson Van Denburg & Campbell Wealth Management Group LLC	12,686	$42K	0.0%	N/A	0.035%
5/3/2023	Liberty Wealth Management LLC	150,400	$0.50M	0.1%	N/A	0.410%
4/26/2023	TRU Independence Asset Management 2 LLC	44,000	$0.15M	0.1%	N/A	0.120%
4/14/2023	Raymond James Financial Services Advisors Inc.	11,248	$37K	0.0%	N/A	0.031%
4/14/2023	Raymond James & Associates	164,703	$0.54M	0.0%	-22.6%	0.449%
11/15/2022	Liberty Wealth Management LLC	40,000	$0.18M	0.0%	+33.3%	0.110%
11/14/2022	Boothbay Fund Management LLC	19,098	$84K	0.0%	-31.5%	0.052%
11/8/2022	IFP Advisors Inc	28,850	$0.15M	0.0%	+45.3%	0.079%
11/3/2022	Creative Planning	30,681	$0.14M	0.0%	N/A	0.084%
10/31/2022	TRU Independence Asset Management 2 LLC	44,000	$0.19M	0.2%	N/A	0.121%
10/25/2022	Janney Montgomery Scott LLC	20,000	$88K	0.0%	N/A	0.055%
10/25/2022	Raymond James & Associates	244,803	$1.08M	0.0%	+30.6%	0.671%
10/20/2022	Jmac Enterprises LLC	40,430	$0.18M	0.1%	-11.0%	0.111%
10/6/2022	Abner Herrman & Brock LLC	280,000	$1.24M	0.2%	+5.7%	0.767%
8/12/2022	Ikarian Capital LLC	253,432	$0.70M	0.1%	-16.7%	0.695%
7/20/2022	Weaver Consulting Group	104,653	$0.29M	0.2%	-19.5%	0.287%
7/11/2022	S.C. Financial Services Inc.	25,471	$70K	0.1%	+66.6%	0.070%
5/6/2022	Weaver Consulting Group	130,000	$0.44M	0.2%	-16.4%	0.356%
4/7/2022	Abner Herrman & Brock LLC	265,000	$0.89M	0.1%	+13.7%	0.726%
2/9/2022	Geneos Wealth Management Inc.	10,100	$40K	0.0%	N/A	0.028%
2/8/2022	Steward Partners Investment Advisory LLC	9,700	$39K	0.0%	-42.9%	0.027%
2/8/2022	Raymond James & Associates	189,503	$0.76M	0.0%	-11.4%	0.522%
2/2/2022	Aptus Capital Advisors LLC	12,500	$50K	0.0%	-21.9%	0.034%
2/1/2022	Weaver Consulting Group	155,500	$0.62M	0.3%	+201.9%	0.429%
1/26/2022	S.C. Financial Services Inc.	15,285	$52K	0.1%	N/A	0.042%
1/13/2022	Abner Herrman & Brock LLC	233,000	$0.93M	0.1%	+13.7%	0.642%
11/15/2021	GSA Capital Partners LLP	172,056	$0.57M	0.1%	+185.6%	0.474%
11/9/2021	BlackRock Inc.	468,967	$1.55M	0.0%	-1.1%	1.293%

Data available starting January 2016

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Today's Range

Now: $0.56

$0.55

$0.58

50 Day Range

MA: $0.64

$0.55

$0.72

52 Week Range

Now: $0.56

$0.52

$2.50

Volume

24,073 shs

Average Volume

409,420 shs

Market Capitalization

$6.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54

Who are the company insiders with the largest holdings of Brainstorm Cell Therapeutics?: Brainstorm Cell Therapeutics' top insider shareholders include:
Chaim Lebovits (CEO)
Ibrahim B Dagher (Insider)
Learn More about top insider investors at Brainstorm Cell Therapeutics.